Abstract: A a multivitamin and mineral dietary supplement includes a base composition of whole aphanizomenon flos-aqua, phycocyanin and phenylethylamine for promoting the body's natural production of stem cells. The production, support and maintenance of these stem cells is enhanced with vitamins and/or minerals. The vitamins and minerals when combined with the base composition promote good health, body repair and longevity.
Abstract: The present invention relates to a composition for the treatment of ballast water containing bacteriophage capable of killing specific target bacteria as an active ingredient in order to eliminate or reduce bacteria including pathogenic bacteria present in ballast water, and a biological treatment method of ballast water.
Abstract: The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus NCC 4007 in combination with a specific probiotic mixture for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.
Type:
Grant
Filed:
February 4, 2010
Date of Patent:
November 27, 2012
Assignee:
Nestec S.A.
Inventors:
Christian Darimont-Nicolau, David Philippe, Catherine Mace, Fabrizio Arigoni
Abstract: The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobacillus rhamnosus CNCM I-4096 for the preparation of a composition to support weight management, promote weight loss and/or to treat obesity.
Type:
Grant
Filed:
February 4, 2010
Date of Patent:
November 27, 2012
Assignee:
Nestec S.A.
Inventors:
Fabrizio Arigoni, Christian Darimont-Nicolau, Catherine Mace
Abstract: The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of the present invention comprising PKC agonist as an active ingredient can be effectively used for the prevention and treatment of absence seizure and for the production of health improving functional food.
Type:
Grant
Filed:
August 5, 2010
Date of Patent:
November 20, 2012
Assignee:
Korea Institute of Science and Technology
Inventors:
Eunji Cheong, Hee-Sup Shin, Yihong Zheng, Kyoobin Lee, Jungryun Lee, Seongwook Kim, Maryam Sanati, Sukyung Lee, Yeon-Soo Kim, Sukchan Lee
Abstract: Disclosed is a method for forming epithelial cells. Said method comprises the steps of aggregating stem cells from differentiated exocrine gland tissue to obtain an organoid body and differentiating at least one portion of the organoid body or a tissue body grown therefrom to obtain epithelial cells. Also disclosed is a cultivation device, particularly for forming differential epithelial cells.
Type:
Grant
Filed:
April 1, 2005
Date of Patent:
October 30, 2012
Assignee:
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung E.V.
Abstract: Embodiments of the present disclosure provide for methods of studying (e.g., detecting, localizing, and/or quantifying) biomarker(s) and the like.
Type:
Grant
Filed:
May 18, 2009
Date of Patent:
October 2, 2012
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Gary M. Glazer, Samira Guccione, Sanjiv S. Gambhir, Aloma L. D'Souza
Abstract: The present invention relates to the use of an ex vivo human skin sample as a biological model, particularly for the assessment of pharmacological and cosmetic effects.
Abstract: The present invention provides methods of cryopreserving stem and progenitor cells in a mammalian placenta; and methods of obtaining fetal stem and progenitor cells from a cryopreserved mammalian placenta. Cells obtained by carrying out the methods can be used in a variety of therapeutic applications.
Type:
Grant
Filed:
June 13, 2008
Date of Patent:
September 25, 2012
Assignee:
Children's Hospital & Research Center at Oakland
Abstract: The present invention relates to a process for producing a fatty acid, which includes feeding a liquid mixture formed of two liquid phases that flow in a co-current manner into a fixed bed-type reaction column packed with immobilized lipase, and performing a hydrolysis reaction when the two liquid phases are in contact with the immobilized lipase in the fixed-bed reaction column; wherein the fixed-bed reaction column comprises partition plates so as to comprise a plurality of tube- shaped structures, wherein each tube-shaped structure has a cross -section which is rectangular, circular, oval, or polygonal in shape with at least a part being unclosed and the cross-section has a representative length of 100 mm or less.
Type:
Grant
Filed:
December 14, 2007
Date of Patent:
August 28, 2012
Assignee:
Kao Corporation
Inventors:
Jun Saito, Yoshitaka Senda, Keigo Hanaki, Toshiteru Komatsu
Abstract: A composition is provided which includes an enriched fish oil as a lipid source. Also provided is a composition which includes a fatty acid of a fish oil and a medium-chain triglyceride, wherein the composition is an oil-in-water emulsion.
Abstract: A bioactive composition includes a hydrogel matrix. At least one protein is immobilized in the hydrogel matrix. The digestive protein has a half-life at least 1000 times longer than the half-life of a free digestive protein counterpart.
Type:
Grant
Filed:
May 9, 2008
Date of Patent:
July 17, 2012
Assignees:
Toyota Motor Engineering & Manufacturing North America, Inc., Toyota Motor Corporation, Regents of the University of Minnesota
Abstract: The invention relates to an improved process of producing a fermentation product, such as ethanol, from starch-containing material using an increased dosage of alpha-amylase during liquefaction, which results in increased conversion of dextrins compared to conventional processes, and/or a reduced dosage of carbohydrate-generating enzyme during simultaneous saccharification and fermentation compared to a conventional process carried out at the same conditions. A process of the invention results in an increased yield. The invention also relates to an improved process of producing a fermentation product resulting in substantially the same yield as a conventional process, wherein reduced dosage of carbohydrate-source generating enzyme is used during simultaneous saccharification and fermentation.
Type:
Grant
Filed:
September 19, 2006
Date of Patent:
July 10, 2012
Assignee:
Novozymes North America, Inc.
Inventors:
George E. Gill, Billie Jean Savage, Swapnil Bhargava
Abstract: A photocatalytic method for the hydroxylation of alkanes involving the use of a Cytochrome P450 class of enzyme as a catalyst which is activated by exposure to a pulsed blue light emitted from a light emitting diode (LED) at 450 nm±25 nm.
Abstract: A novel strain of Bacillus subtilis EB120 shows high antagonistic activity for controlling various plant diseases including barley powdery mildew, cucumber powdery mildew, red pepper anthracnose, rice blast, tomato gray mold, tomato late blight and wheat leaf rust, it can be effectively used as a microbioside for biologically controlling the plant diseases.
Type:
Grant
Filed:
March 23, 2005
Date of Patent:
June 19, 2012
Assignee:
Korea Research Institute of Chemical Technology
Inventors:
Kwang Yun Cho, Jin-Cheol Kim, Gyung Ja Choi, Seon-Woo Lee, Yong Ho Choi, Kyoung Soo Jang, He Kyoung Lim
Abstract: The invention provides methods for producing methanol, higher alcohols (containing 2 or more carbons), in particular ethanol, or diesel fuel from biological wastes such as manure, sewage, and crop wastes, as well as from other organic materials. In the methods, organic material is first fermented by anaerobic microorganisms to a biogas consisting primarily of methane and carbon dioxide. The biogas is then converted to synthesis gas consisting primarily of CO and H2. The synthesis gas is then contacted with a liquid fuel production catalyst to synthesize higher alcohols or other liquid fuels. The invention involves converting CO2 in the biogas to synthesis gas by combining a CO2 reforming reaction with steam reforming or partial oxidation to convert the biogas to synthesis gas. The invention also provides methods involving recirculating CO2 from the output of the liquid fuel production reaction to one or more of the fermentation reaction, the CO2 reforming reaction, or the liquid fuel production reaction.
Abstract: A porous film is used as a cell culture substrate that is a scaffold for a spheroid. The porous film has a plurality of pores whose diameters gradually increase in a direction A. The diameters of the pores gradually increase from a first area P1 to a third area P3 in this order. The first to the third areas P1 to P3 are located on the porous film along the direction A. The diameters and depths of the pores increase in proportion to the distance in the direction A.
Abstract: It is an object of the present invention to provide: a novel thiol-detecting reagent, which can be used in vivo and which solves the problem regarding the generation of background fluorescence due to hydrolysis; and a method for detecting thiol using the aforementioned reagent. The present invention provides a compound represented by the following formula (1): wherein each R2 independently represents an alkyl group containing 1 to 6 carbon atoms, a halogen atom, or a hydrogen atom.
Type:
Grant
Filed:
January 30, 2009
Date of Patent:
May 29, 2012
Assignee:
Riken
Inventors:
Hiroshi Abe, Yoshihiro Ito, Aya Shibata, Mika Ito